Paul A. Jones
Analyst · Tim Ramey from D.A
Thanks, Dave. Sales growth this quarter was led by our Asia Pacific region, where many of our markets continue to generate solid sales growth. Sales increased 36.3% in Greater China and 9.3% in Southeast Asia/Pacific. We were also pleased to see 19% sales growth in South Korea in our North Asia region, which was driven by strong increase in customers as well as price adjustments implemented earlier this year. The Greater China growth was driven by strong results in each of the markets in this region, but was led by Mainland China. The number of Active Associates in Greater China increased 18.4%, which was again led by significant Associate growth in Mainland China. We're pleased with our continued success in this region, particularly in Mainland China, where sales were approximately $3.5 million stronger than expected. We believe that these better-than-expected results are due to continued excitement and momentum from our sold-out Asia Pacific Convention that was held in this region during the first quarter and the emergence of new Associate leaders and customers in China, as we are beginning to see a number of Associates in that market advance up through our leadership ranks. We also believe that the 3 additional direct-selling licenses that were granted during the first quarter, as well as our significant offering of licensed USANA products, are contributing to our success in Mainland China. While we are encouraged by our results in Greater China for the quarter, we are conscious about the events that accelerated our performance in the region. Both the carryover momentum from our Asia Pacific Convention and the sales ahead of our worldwide policy change has meaningfully contributed to our results in this region for the quarter. Additionally, we continue to anticipate that our results in Hong Kong will taper and that we will continue to grow in Mainland China as we focus our efforts and resources on this market. Now just to clarify some details about our business in China. We maintain a direct-selling license in the province of Beijing and we're also granted direct-selling licenses in 3 additional provinces during the first quarter of this year. In China, we sell 8 USANA-branded products, 6 Sensé-branded products and 10 BabyCare-branded products, all of which has been registered with and approved by the Chinese government. Our Associates around the world are required to comply with local laws and regulations, as well as our internal policies and procedures. We continually update our policies and procedures to ensure that they are in accordance with best practices. The policy I mentioned a moment ago is simply one example of a policy that we have implemented or modified during the last year to strengthen our business. We are aggressive in ensuring that our Associates comply with our policies and procedures and will continue to be aggressive going forward. Turning now to Southeast Asia/Pacific. Sales growth in this region was again driven by double-digit sales and customer growth in the Philippines. We continue to see solid growth in the Philippines, albeit at the reduced rate we anticipated. We were also pleased with our results in Australia and New Zealand during the quarter, where the number of Active Associates increased over 5% and the number of Preferred Customers increased 15%. We believe that the success and momentum that we are beginning to see in these markets is directly related to the pricing initiative we announced earlier this year. As a reminder, we implemented price reductions that were designed to help expand our customer base in several of our mature markets. They better align our product pricing with the economic and competitive environment while incenting Associates to purchase within their home market. We also saw solid sales growth in Singapore this quarter, which can primarily be attributed to the sales of our MyHealthPak product, which have improved noticeably throughout Asia. Remember that our entire Asia Pacific region is serviced by Singapore for our MyHealthPak product. Turning now to North America. Sales for this region continued to improve and increased 6.9%, which was largely the result of strong sales growth in Mexico, as well as sales growth in the U.S. and Canada. Our sales growth in Mexico was driven by double-digit increases in both Associates and Preferred Customers, as well as price increases that were implemented during the first quarter. Sales growth in the U.S. was driven by increased Associate productivity and price increases on certain of our products that were implemented during the first quarter. In addition, you may recall Dave discussing on previous calls the iPad promotion and True Health Assessment initiative. Both of these programs generated a lot of excitement with our Associates during the first quarter. The enthusiasm continued to build during the second quarter and we are continuing to utilize and promote the True Health Assessment. In Canada, we are beginning to see improvements in both customer counts and productivity, which we believe is the early result of the price reductions made in the first quarter. Although this pricing initiative is still in the early stages, we are pleased with the results so far and expect it to generate both customer and sales growth over the long term in Canada and the other mature markets that were targeted. Let's turn now to the income statement. Gross margins improved 50 basis points year-over-year, largely due to a decrease in cost of goods sold, which can mostly be attributed to production efficiencies. These efficiencies were partially offset by an unfavorable change in sales mix by market. Associate incentives expensed for the quarter decreased to 41.1% of net sales compared to 44.1% in the prior year quarter. This decrease can primarily be attributed to the change -- to the Lifetime Matching Bonus program launched in the second quarter of 2012. In a moment, Dave will walk you through our plans for Associate incentive expenses for the remainder of this year and going forward. SG&A in the second quarter was 22.7% of net sales, a relative decrease of 10 basis points from the second quarter of 2012. This relative decrease is largely due to leverage gained from higher net sales. On an absolute basis, SG&A increased as a result of the costs associated with supporting a higher sales base, which largely can be attributed to higher wages and benefits. Our effective tax rate for the quarter was 33.4% of pretax income compared to 32.8% in the prior year. We expect our effective tax rate for the year to range between 33% and 33.5%. Net earnings for the first quarter increased to $24.2 million, an improvement of 44.6% compared with the prior year period. This increase was due to higher net sales, higher relative gross margins and lower relative operating expenses for the quarter. Earnings per share for the quarter increased nearly 55% to a record $1.72 per diluted share. This increase can be attributed to higher net earnings and a lower number of shares outstanding from share repurchases over the last 12 months. We did not repurchase any shares during the quarter and there's approximately $13.6 million remaining under our board-authorized repurchase program. Our diluted share count as of the end of the quarter was 14.1 million shares. Turning to the balance sheet. We continue to generate strong cash from operations and ended the quarter with $96 million in cash. Cash generated from operations in the second quarter totaled nearly $27 million. Before turning the call back over to Dave, I'd like to reiterate how pleased we are with this quarter's results and more specifically, with the underlying strength of our business and the financial strength of the company. With that, I will turn the call to Dave to review some new initiatives and our guidance.